tomeko

X-linked dominant chondrodysplasia, Chassaing-Lacombe type

Just diagnosed with X-linked dominant chondrodysplasia, Chassaing-Lacombe type?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees X-linked dominant chondrodysplasia, Chassaing-Lacombe type, look for clinical trials, and connect with others living with it — all in one place.

Open the full X-linked dominant chondrodysplasia, Chassaing-Lacombe type hub →

Overview

X-linked dominant chondrodysplasia, Chassaing-Lacombe type is a rare condition. Also known as X-linked dominant chondrodysplasia-hydrocephaly-microphthalmia syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for X-linked dominant chondrodysplasia, Chassaing-Lacombe type so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:163966 · OMIM 300863 · ICD-10 Q78.8 · GARD 0017007

Find care for X-linked dominant chondrodysplasia, Chassaing-Lacombe type

Authoritative references for X-linked dominant chondrodysplasia, Chassaing-Lacombe type

Common questions

I was just diagnosed with X-linked dominant chondrodysplasia, Chassaing-Lacombe type — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees X-linked dominant chondrodysplasia, Chassaing-Lacombe type, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for X-linked dominant chondrodysplasia, Chassaing-Lacombe type?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat X-linked dominant chondrodysplasia, Chassaing-Lacombe type, filtered to your area.

Are there clinical trials for X-linked dominant chondrodysplasia, Chassaing-Lacombe type?

Tomeko shows live, recruiting studies for X-linked dominant chondrodysplasia, Chassaing-Lacombe type from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com